COVID-19 severity and waning immunity after up to 4 mRNA vaccine doses in 73 608 patients with cancer and 621 475 matched controls in Singapore: a nationwide cohort study
Importance: Despite patients with cancer being at risk of poor outcomes from COVID-19, there are few published studies for vaccine efficacy in this group, with suboptimal immunogenicity and waning vaccine efficacy described in small studies being a concern. Objective: To assess the incidence rate of...
Hoofdauteurs: | , , , , , , , , , , , , , , , , , , |
---|---|
Andere auteurs: | |
Formaat: | Journal Article |
Taal: | English |
Gepubliceerd in: |
2024
|
Onderwerpen: | |
Online toegang: | https://hdl.handle.net/10356/174182 |